eCARTv5 Clinical Deterioration Suite (eCART) vs ASCO Guidelines Assistant

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

eCARTv5 Clinical Deterioration Suite (eCART)

by AgileMD

ASCO Guidelines Assistant

by American Society of Clinical Oncology (ASCO) / Google Cloud

AI Verdict

Tool A, eCARTv5, is an AI-powered Software as a Medical Device that predicts clinical deterioration in hospitalized adult patients, integrating with EHRs to guide care with embedded clinical pathways. Tool B, ASCO Guidelines Assistant, is an AI tool that helps oncologists quickly access evidence-based clinical guidelines to support patient care decisions, specifically within oncology. While both are AI-powered clinical decision support tools, their core functionalities and target applications differ significantly, making them adjacent rather than direct competitors.

Choose eCARTv5 Clinical Deterioration Suite (eCART) if…

Choose eCARTv5 Clinical Deterioration Suite if your hospital needs an AI-powered, real-time early warning system to continuously monitor hospitalized adult patients for the risk of clinical deterioration. This tool is ideal for critical care, emergency medicine, and hospital medicine departments aiming to proactively identify and manage at-risk patients, reduce ICU transfers, and improve patient outcomes through embedded clinical pathways. It's particularly suited for organizations seeking an FDA-cleared SaMD that integrates seamlessly with existing EHRs and minimizes false alarms.

View eCARTv5 Clinical Deterioration Suite (eCART) →

Choose ASCO Guidelines Assistant if…

Choose ASCO Guidelines Assistant if you are an oncologist seeking rapid, evidence-based clinical guidance directly from ASCO's comprehensive library to support patient care decisions. This AI tool is best for hematology and oncology specialists who need timely, trustworthy information with clear citations, an interactive chat function for specific questions, and dynamic updates as new guidelines are published. It's particularly valuable for ASCO members looking for a convenient, cloud-based solution accessible via the ASCO Member app.

View ASCO Guidelines Assistant →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	ASCO Guidelines Assistant
Pricing	Contact vendor for tailored quote.	Paid membership
Deployment	Cloud-based SaaS, integrated directly into Electronic Health Record (EHR) systems.	Cloud-based
BAA Available	Unknown	Yes AI-estimated
FDA Status	1 AI-estimated	Not applicable AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ASCO Guidelines Assistant

The ASCO Guidelines Assistant offers an interactive chat function and dynamic user experience, allowing oncologists to quickly ask questions and receive clear, cited information from guidelines. This conversational approach is generally considered more intuitive and user-friendly for information retrieval compared to traditional interfaces. AgileMD's eCARTv5 focuses on EHR integration and real-time data, which is efficient for continuous monitoring but less about direct, interactive information access for the clinician.

Clinical Value

eCARTv5 Clinical Deterioration Suite (eCART)

eCARTv5 provides continuous, AI-powered prediction of clinical deterioration (death or ICU transfer) in hospitalized patients, integrating with EHRs and guiding care with embedded clinical pathways. This directly impacts patient outcomes by enabling early intervention. The ASCO Guidelines Assistant, while valuable for quick access to evidence-based guidelines, serves as a reference tool to support decision-making rather than actively predicting patient-specific risks or guiding real-time care.

Pricing & Value

ASCO Guidelines Assistant

The ASCO Guidelines Assistant is available free to ASCO members, offering significant value to a large professional oncology community. AgileMD's eCARTv5 requires prospective customers to contact the vendor for a tailored quote, indicating a potentially higher and less transparent cost structure.

Enterprise Readiness

eCARTv5 Clinical Deterioration Suite (eCART)

AgileMD's eCARTv5 is an FDA-cleared Software as a Medical Device (SaMD) with seamless EHR integration, designed for continuous patient risk assessment in hospitalized adult patients across various specialties. It has been validated with nearly two million hospitalizations across 21 hospitals, demonstrating its scalability and robustness for enterprise-level deployment. The ASCO Guidelines Assistant, while a collaboration with Google Cloud and HIPAA compliant, is primarily a reference tool for oncologists, and its enterprise deployment capabilities beyond individual member access are not as explicitly detailed.

Innovation

Tie

Both tools demonstrate significant innovation in their respective domains. eCARTv5 utilizes advanced AI for continuous, real-time clinical deterioration prediction and integrates deeply into EHR workflows, representing a proactive approach to patient safety. The ASCO Guidelines Assistant leverages generative AI (Google Cloud's Vertex AI and Gemini models) to provide an interactive chat experience for navigating complex clinical guidelines, offering a novel way for oncologists to access critical information. Both are pushing boundaries in healthcare AI.

Support & Docs

Tie

Both tools are backed by reputable organizations (AgileMD with extensive research and ASCO/Google Cloud). AgileMD highlights its '88+ Publications' and '14yr+ Experience' and offers reporting and benchmarking capabilities, implying strong documentation and support for its complex system. The ASCO Guidelines Assistant, being a collaboration with Google Cloud, is expected to have robust technical support and is updated as new guidelines are published, with users able to provide feedback for refinement. Without specific comparative details on support channels or documentation comprehensiveness, it's difficult to definitively pick a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	ASCO Guidelines Assistant
Tool Name	eCARTv5 Clinical Deterioration Suite (u0093eCARTu0094)	ASCO Guidelines Assistant
Company	AgileMD	American Society of Clinical Oncology (ASCO) / Google Cloud
Description	FDA-cleared, AI-powered Software as a Medical Device (SaMD) that integrates with EHRs to continuously assess and predict the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients, guiding care with embedded clinical pathways.	AI tool that helps oncologists quickly access evidence-based clinical guidelines, providing timely and trustworthy information to support patient care decisions.
Primary Function	AI-powered clinical deterioration prediction and continuous patient risk assessment	Quickly access evidence-based clinical guidelines
Specialties	Critical Care, Emergency Medicine, Hospital Medicine	Hematology, Oncology
Key Features	AI-powered clinical deterioration prediction, Continuous patient risk assessment (death or ICU transfer), EHR integration with real-time data (up to 97 variables), Embedded clinical pathways for care guidance, Early warning system (alerts hours before critical illness), Risk stratification (eCART score and risk designation), Minimizes false alarms and clinician workload, Reporting and benchmarking capabilities	Quickly navigate ASCO's full library of clinical practice guidelines, Receive timely and trustworthy information with clear citations and sources, Interactive chat function for asking questions, Ability to ask follow-up questions, Dynamic user experience, Updated as new guidelines are published or revised, Available through the ASCO Member app

Videos

Demos, reviews, and walkthroughs featuring eCARTv5 Clinical Deterioration Suite (eCART) and ASCO Guidelines Assistant.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into a physician's existing workflow and EHR?

eCARTv5 integrates directly into EHR systems, continuously assessing patient risk using up to 97 real-time variables like vital signs, lab results, and nursing assessments, and guiding care with embedded clinical pathways. The ASCO Guidelines Assistant, available through the ASCO Member app and website, offers an interactive chat function to quickly access ASCO's clinical practice guidelines, providing timely and trustworthy information with citations to support patient care decisions.

What are the key differences in accuracy and sensitivity between eCARTv5 and ASCO Guidelines Assistant?

eCARTv5 is an AI-powered predictive model that continuously assesses and predicts the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients. It has demonstrated high accuracy, with an AUROC of 0.895 in one study, outperforming other early warning scores. The ASCO Guidelines Assistant, on the other hand, focuses on providing accurate and trustworthy information from ASCO's evidence-based clinical practice guidelines, with clear citations and sources. While it aims for accuracy in information retrieval, it is not a clinical decision support tool and does not provide predictive analytics for patient deterioration.

What is the learning curve like for each tool, and what kind of support is available?

eCARTv5 is designed with an intuitive user interface and well-tested clinical workflow to minimize false alarms and decrease clinician workload, suggesting a manageable learning curve. AgileMD offers reporting and benchmarking capabilities, which can aid in understanding and optimizing its use. The ASCO Guidelines Assistant is designed for quick and easy navigation of guidelines through an intuitive chat function, allowing users to ask follow-up questions. It is expected to learn and improve through user feedback.

How quickly can a physician expect to see value from implementing each tool?

eCARTv5 aims to provide early detection of clinical deterioration, potentially hours before critical illness, which can lead to improved patient outcomes and resource allocation. This suggests a rapid time-to-value by enabling timely interventions. The ASCO Guidelines Assistant offers immediate access to evidence-based guidelines, helping oncologists make faster, informed decisions and potentially reducing the time spent searching for information.

What are the considerations for rolling out these tools across multiple clinical sites?

eCARTv5 has been validated in a multicenter study across 21 hospitals, demonstrating consistent accuracy across diverse patient demographics and medical conditions, which suggests it is well-suited for multi-site rollouts. The ASCO Guidelines Assistant is available through the ASCO Member app and website, making it accessible to individual oncologists across various settings. Its cloud-based deployment also facilitates broader access.

In what clinical contexts would each tool be most beneficial for a physician?

eCARTv5 is most beneficial in critical care, emergency medicine, and hospital medicine settings for continuously assessing and predicting the risk of clinical deterioration in hospitalized adult patients, enabling early intervention and guiding care with embedded clinical pathways. The ASCO Guidelines Assistant is specifically designed for oncologists and hematologists, providing quick access to evidence-based clinical guidelines to support patient care decisions in oncology. It is a voluntary educational resource and not a clinical decision support tool.